SCHEMBL459152

SCHEMBL459152

CC(C)(C)OC(=O)N[C@@]1(Cc2ccccc2)CNC[C@@H]1c1ccc(F)cc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
NR3C2 P08235 2/20 0.35
MC4R P32245 2/20 0.35
KCNH2 Q12809 1/20 0.35
ATM Q13315 2/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
DPP8 Q6V1X1 1/20 0.34
DPP9 Q86TI2 1/20 0.34
MC1R Q01726 1/20 0.34
JAK2 O60674 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34
RORC P51449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1720734 0.93 KMT2A (0.40) CTSSCTSKATMKMT2AMEN1
SCHEMBL462003 0.91 IDO1 (0.36) CTSSCTSKATMKMT2ATP53
SCHEMBL462095 0.88 RORC (0.36) CTSSCTSKATMKMT2ATP53
SCHEMBL459500 0.86 HTT (0.34) ATMKMT2AMEN1TP53HTT
SCHEMBL457233 0.85 KMT2A (0.32) CTSSATMKMT2AMEN1RORC
SCHEMBL2013227 0.84 CA12 (0.34) CTSSKMT2ADPP8DPP9CA12
SCHEMBL1726610 0.82 KMT2A (0.37) CTSSCTSKKMT2AHTTRORC
SCHEMBL2016334 0.82 SLC6A2 (0.39) KMT2AL3MBTL1ADRA1DADRA1AADRA1B
SCHEMBL2012019 0.79 KDM1A (0.39) KMT2ACA12CA1CA7CA14
SCHEMBL2226908 0.79 KMT2A (0.36) ATMKMT2ACA12CA1CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406251-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS Prosidion Limited (GB) 2012-01-18 EP disclosed
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 WO disclosed
WO-2010103334-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2010-09-16 WO disclosed